Declaration of competing financial interests
From the following article
Victor Nizet & Marc E Rothenberg
Nature Medicine 14, 910 - 912 (2008)
doi:10.1038/nm0908-910
Declaration: M.E.R. is associated with the following companies that are pursuing drugs that target gastrointestinal eosinophils: Ception Therapeutics (consultant and stock owner), Novartis (consultant) and Merck (consultant).
